세계의 세보플루란 마취제 시장 인사이트, 예측(-2030년)

The global Sevoflurane Anesthesia Drugs market is projected to grow from US$ 1262.03 million in 2024 to US$ 1612.53 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.17% during the forecast period.

The United States & Canada market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 310.13 million in 2024 to reach $ 379.62 million by 2030, at a CAGR of 3.43% during the forecast period of 2024 through 2030.

The China market for Sevoflurane Anesthesia Drugs is estimated to increase from $ 525.87 million in 2024 to reach $ 706.44 million by 2030, at a CAGR of 5.04% during the forecast period of 2024 through 2030.

The global key manufacturers of Sevoflurane Anesthesia Drugs include Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc. In 2023, the global top five players had a share approximately 91.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Sevoflurane Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sevoflurane Anesthesia Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sevoflurane Anesthesia Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sevoflurane Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sevoflurane Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sevoflurane Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, etc.

Market Segmentation

By Company

• Hengrui
• Baxter
• Maruishi
• AbbVie
• Piramal
• PT Novell Pharmaceutical
• Lunan Pharma
• Hana Pharm
• Hebei Yipin Pharmaceutical

Segment by Type

• 250ml/Bottle
• 100ml/Bottle
• Other

Segment by Application

• Hospital
• Clinic
• Other

Segment by Region

North America

• U.S.
• Canada

China

Asia (Ex. China)

• Japan
• South Korea
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Middle East, Africa, Latin America

• Brazil
• Mexico
• Middle East
• Africa
• Other

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Sevoflurane Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Sevoflurane Anesthesia Drugs manufacturer's competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (Ex. China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sevoflurane Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

• 1.1 Sevoflurane Anesthesia Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 250ml/Bottle
  • 1.2.3 100ml/Bottle
• 1.3 Market by Application
  • 1.3.1 Global Sevoflurane Anesthesia Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 EXECUTIVE SUMMARY

• 2.1 Global Sevoflurane Anesthesia Drugs Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Sevoflurane Anesthesia Drugs Revenue by Region
  • 2.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Sevoflurane Anesthesia Drugs Revenue by Region (2019-2024)
  • 2.2.3 Global Sevoflurane Anesthesia Drugs Revenue by Region (2025-2030)
  • 2.2.4 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2019-2030)
• 2.3 Global Sevoflurane Anesthesia Drugs Sales Estimates and Forecasts 2019-2030
• 2.4 Global Sevoflurane Anesthesia Drugs Sales by Region
  • 2.4.1 Global Sevoflurane Anesthesia Drugs Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Sevoflurane Anesthesia Drugs Sales by Region (2019-2024)
  • 2.4.3 Global Sevoflurane Anesthesia Drugs Sales by Region (2025-2030)
  • 2.4.4 Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2019-2030)
• 2.5 North America
• 2.6 Europe
• 2.7 China
• 2.8 Asia (Ex. China)
• 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

• 3.1 Global Sevoflurane Anesthesia Drugs Sales by Manufacturers
  • 3.1.1 Global Sevoflurane Anesthesia Drugs Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Sevoflurane Anesthesia Drugs Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top Largest Manufacturers of Sevoflurane Anesthesia Drugs in 2023
• 3.2 Global Sevoflurane Anesthesia Drugs Revenue by Manufacturers
  • 3.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top Companies by Sevoflurane Anesthesia Drugs Revenue in 2023
• 3.3 Global Key Players of Sevoflurane Anesthesia Drugs, Industry Ranking, 2022 VS 2023
• 3.4 Global Sevoflurane Anesthesia Drugs Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Sevoflurane Anesthesia Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Product Offered
• 3.8 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Founded Date
• 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

• 4.1 Global Sevoflurane Anesthesia Drugs Sales by Type
  • 4.1.1 Global Sevoflurane Anesthesia Drugs Historical Sales by Type (2019-2024)
  • 4.1.2 Global Sevoflurane Anesthesia Drugs Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2019-2030)
• 4.2 Global Sevoflurane Anesthesia Drugs Revenue by Type
  • 4.2.1 Global Sevoflurane Anesthesia Drugs Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Sevoflurane Anesthesia Drugs Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2019-2030)
• 4.3 Global Sevoflurane Anesthesia Drugs Price by Type
  • 4.3.1 Global Sevoflurane Anesthesia Drugs Price by Type (2019-2024)
  • 4.3.2 Global Sevoflurane Anesthesia Drugs Price Forecast by Type (2025-2030)

5 MARKET SIZE BY APPLICATION

• 5.1 Global Sevoflurane Anesthesia Drugs Sales by Application
  • 5.1.1 Global Sevoflurane Anesthesia Drugs Historical Sales by Application (2019-2024)
  • 5.1.2 Global Sevoflurane Anesthesia Drugs Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2019-2030)
• 5.2 Global Sevoflurane Anesthesia Drugs Revenue by Application
  • 5.2.1 Global Sevoflurane Anesthesia Drugs Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Sevoflurane Anesthesia Drugs Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2019-2030)
• 5.3 Global Sevoflurane Anesthesia Drugs Price by Application
  • 5.3.1 Global Sevoflurane Anesthesia Drugs Price by Application (2019-2024)
  • 5.3.2 Global Sevoflurane Anesthesia Drugs Price Forecast by Application (2025-2030)

6 NORTH AMERICA

• 6.1 North America Sevoflurane Anesthesia Drugs Market Size by Type
  • 6.1.1 North America Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
  • 6.1.2 North America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
• 6.2 North America Sevoflurane Anesthesia Drugs Market Size by Application
  • 6.2.1 North America Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
  • 6.2.2 North America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
• 6.3 North America Sevoflurane Anesthesia Drugs Market Size by Country
  • 6.3.1 North America Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 North America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
  • 6.3.3 North America Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 EUROPE

• 7.1 Europe Sevoflurane Anesthesia Drugs Market Size by Type
  • 7.1.1 Europe Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
  • 7.1.2 Europe Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
• 7.2 Europe Sevoflurane Anesthesia Drugs Market Size by Application
  • 7.2.1 Europe Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
  • 7.2.2 Europe Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
• 7.3 Europe Sevoflurane Anesthesia Drugs Market Size by Country
  • 7.3.1 Europe Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
  • 7.3.3 Europe Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 CHINA

• 8.1 China Sevoflurane Anesthesia Drugs Market Size by Type
  • 8.1.1 China Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
  • 8.1.2 China Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
• 8.2 China Sevoflurane Anesthesia Drugs Market Size by Application
  • 8.2.1 China Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
  • 8.2.2 China Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)

9 ASIA (EX. CHINA)

• 9.1 Asia Sevoflurane Anesthesia Drugs Market Size by Type
  • 9.1.1 Asia Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
  • 9.1.2 Asia Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
• 9.2 Asia Sevoflurane Anesthesia Drugs Market Size by Application
  • 9.2.1 Asia Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
  • 9.2.2 Asia Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
• 9.3 Asia Sevoflurane Anesthesia Drugs Market Size by Region
  • 9.3.1 Asia Sevoflurane Anesthesia Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Sevoflurane Anesthesia Drugs Revenue by Region (2019-2030)
  • 9.3.3 Asia Sevoflurane Anesthesia Drugs Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 Southeast Asia
  • 9.3.7 India
  • 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

• 10.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Sevoflurane Anesthesia Drugs Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Middle East
  • 10.3.7 Africa

11 CORPORATE PROFILE

• 11.1 Hengrui
  • 11.1.1 Hengrui Company Information
  • 11.1.2 Hengrui Overview
  • 11.1.3 Hengrui Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Hengrui Sevoflurane Anesthesia Drugs Product Introduction
  • 11.1.5 Hengrui Recent Developments
• 11.2 Baxter
  • 11.2.1 Baxter Company Information
  • 11.2.2 Baxter Overview
  • 11.2.3 Baxter Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Baxter Sevoflurane Anesthesia Drugs Product Introduction
  • 11.2.5 Baxter Recent Developments
• 11.3 Maruishi
  • 11.3.1 Maruishi Company Information
  • 11.3.2 Maruishi Overview
  • 11.3.3 Maruishi Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Maruishi Sevoflurane Anesthesia Drugs Product Introduction
• 11.4 AbbVie
  • 11.4.1 AbbVie Company Information
  • 11.4.2 AbbVie Overview
  • 11.4.3 AbbVie Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 AbbVie Sevoflurane Anesthesia Drugs Product Introduction
  • 11.4.5 AbbVie Recent Developments
• 11.5 Piramal
  • 11.5.1 Piramal Company Information
  • 11.5.2 Piramal Overview
  • 11.5.3 Piramal Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Piramal Sevoflurane Anesthesia Drugs Product Introduction
• 11.6 PT Novell Pharmaceutical
  • 11.6.1 PT Novell Pharmaceutical Company Information
  • 11.6.2 PT Novell Pharmaceutical Overview
  • 11.6.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
• 11.7 Lunan Pharma
  • 11.7.1 Lunan Pharma Company Information
  • 11.7.2 Lunan Pharma Overview
  • 11.7.3 Lunan Pharma Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Lunan Pharma Sevoflurane Anesthesia Drugs Product Introduction
• 11.8 Hana Pharm
  • 11.8.1 Hana Pharm Company Information
  • 11.8.2 Hana Pharm Overview
  • 11.8.3 Hana Pharm Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Hana Pharm Sevoflurane Anesthesia Drugs Product Introduction
• 11.9 Hebei Yipin Pharmaceutical
  • 11.9.1 Hebei Yipin Pharmaceutical Company Information
  • 11.9.2 Hebei Yipin Pharmaceutical Overview
  • 11.9.3 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Product Introduction
  • 11.9.5 Hebei Yipin Pharmaceutical Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

• 12.1 Sevoflurane Anesthesia Drugs Industry Chain Analysis
• 12.2 Sevoflurane Anesthesia Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Sevoflurane Anesthesia Drugs Production Mode & Process
• 12.4 Sevoflurane Anesthesia Drugs Sales and Marketing
  • 12.4.1 Sevoflurane Anesthesia Drugs Sales Channels
  • 12.4.2 Sevoflurane Anesthesia Drugs Distributors
• 12.5 Sevoflurane Anesthesia Drugs Customers

13 SEVOFLURANE ANESTHESIA DRUGS MARKET DYNAMICS

• 13.1.1 Sevoflurane Anesthesia Drugs Industry Trends
• 13.1.2 Sevoflurane Anesthesia Drugs Market Drivers
• 13.1.3 Sevoflurane Anesthesia Drugs Market Challenges
• 13.1.4 Sevoflurane Anesthesia Drugs Market Restraints

14 KEY FINDINGS IN THE GLOBAL SEVOFLURANE ANESTHESIA DRUGS STUDY

15 APPENDIX

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer